108 studies found for:    Open Studies | "Exanthema"
Show Display Options
Rank Status Study
1 Recruiting 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX
Condition: Rash
Intervention: Drug: Pimecrolimus
2 Not yet recruiting Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream Lotion, for EGFR'I Induced Acneiform Rash
Condition: Acneiform Rash
Interventions: Drug: Threolone ointment;   Drug: ointment Synthomycine;   Drug: Aqua cream lotion
3 Not yet recruiting Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis
Condition: Diaper Rash
Interventions: Other: Moussik Diaper Rash Mousse;   Other: Desitin Creamy Ointment
4 Recruiting Regulatory T Cells (Tregs) in Polymorphic Light Eruption
Conditions: Polymorphic Light Eruption;   Psoriasis;   Atopic Eczema
Intervention:
5 Recruiting Vitamin D Supplementation in Polymorphic Light Eruption
Condition: Polymorphic Light Eruption
Interventions: Drug: Oral Vitamin D 3;   Drug: Miglyol 812 N
6 Recruiting A Trial of Tooth Mousse to Remineralise Post-orthodontic Treatment White Spot Lesions
Conditions: Demineralisation;   White Spot Lesions;   Orthodontic Treatment
Intervention: Device: Tooth Mousse creme (Casein Phosphopeptide)(RECALDENT)
7 Unknown  Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients
Condition: Tooth; Lesion, White Spot Lesions
Interventions: Drug: elmex® gelée;   Drug: negative control (placebo)
8 Not yet recruiting Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment
Condition: Cutaneous Rash
Interventions: Drug: Desloratadine + Prednisolone;   Drug: Dexchlorpheniramine + Betamethasone
9 Recruiting FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema
Condition: Colorectal Cancer Metastatic
Intervention: Drug: FOLFIRI + Cetuximab
10 Unknown  Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI)
Conditions: Cancer;   Skin Rash
Intervention: Other: cream
11 Not yet recruiting A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI
Condition: Rash Due to Epidermal Growth Factor Receptor Inhibitors
Interventions: Drug: RECONVAL CREAM;   Drug: PLACEBO
12 Recruiting Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Other: EVOZAC Calming Skin Spray;   Other: Physiological saline
13 Not yet recruiting Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab
Condition: Colorectal Cancer Metastatic
Intervention: Drug: Cetuximab
14 Unknown  Elmex Gel Efficacy in Preventing White Spot Lesions
Condition: Dental Caries
Intervention: Drug: elmex gel
15 Recruiting Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Pan retinal Photocoagulation
16 Not yet recruiting F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
Condition: Cerebral Amyloid Angiopathy
Intervention:
17 Unknown  An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots
Condition: HIV Infections
Intervention: Drug: HEC placebo gel
18 Recruiting Multi-Compression Spot Mammography
Condition: Breast Diseases
Intervention:
19 Recruiting Resin Infiltratration on the Sealing of Proximal Early Caries
Condition: Tooth; Lesion, White Spot Lesions
Interventions: Other: ICON;   Behavioral: instruction oral hygiene
20 Recruiting The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years